These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1482641

  • 1. The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure.
    Túri S, Németh I, Varga I, Bodrogi T, Matkovics B.
    Pediatr Nephrol; 1992 Nov; 6(6):536-41. PubMed ID: 1482641
    [Abstract] [Full Text] [Related]

  • 2. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis.
    Németh I, Túri S, Haszon I, Bereczki C.
    Pediatr Nephrol; 2000 Jan; 14(1):13-7. PubMed ID: 10654322
    [Abstract] [Full Text] [Related]

  • 3. Oxidative damage of red blood cells in haemolytic uraemic syndrome.
    Túri S, Németh I, Vargha I, Matkovics B.
    Pediatr Nephrol; 1994 Feb; 8(1):26-9. PubMed ID: 8142220
    [Abstract] [Full Text] [Related]

  • 4. Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
    Georgatzakou HT, Tzounakas VL, Kriebardis AG, Velentzas AD, Papageorgiou EG, Voulgaridou AI, Kokkalis AC, Antonelou MH, Papassideri IS.
    Eur J Haematol; 2017 Jun; 98(6):590-600. PubMed ID: 28295628
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Erythrocyte defense mechanisms against free oxygen radicals in haemodialysed uraemic children.
    Túri S, Németh I, Vargha I, Matkovics B, Dobos E.
    Pediatr Nephrol; 1991 Mar; 5(2):179-83. PubMed ID: 2031830
    [Abstract] [Full Text] [Related]

  • 8. Oxidative stress and antioxidant defense mechanism in glomerular diseases.
    Túri S, Németh I, Torkos A, Sághy L, Varga I, Matkovics B, Nagy J.
    Free Radic Biol Med; 1997 Mar; 22(1-2):161-8. PubMed ID: 8958140
    [Abstract] [Full Text] [Related]

  • 9. Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.
    Pietrzak I, Bladek K, Bulikowski W.
    Magnes Res; 2002 Dec; 15(3-4):229-36. PubMed ID: 12635877
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ratio of baseline erythropoietin (EPO) level and corrected reticulocyte count as an indicator for a favourable response to recombinant human erythropoietin (rhEPO) therapy in anaemic cancer patients.
    Charuruks N, Voravud N, Limpanasithikul W.
    J Clin Lab Anal; 2001 Dec; 15(5):260-6. PubMed ID: 11574955
    [Abstract] [Full Text] [Related]

  • 12. Protective effect of recombinant human erythropoietin against cisplatin-induced oxidative stress and nephrotoxicity in rat kidney.
    Rjiba-Touati K, Boussema IA, Belarbia A, Achour A, Bacha H.
    Int J Toxicol; 2011 Oct; 30(5):510-7. PubMed ID: 22013135
    [Abstract] [Full Text] [Related]

  • 13. Lipid peroxidation and antioxidant activity in chronic haemodialysis patients treated with recombinant human erythropoietin.
    Cavdar C, Camsari T, Semin I, Gönenc S, Acikgöz O.
    Scand J Urol Nephrol; 1997 Aug; 31(4):371-5. PubMed ID: 9290168
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rhEPO treatment.
    Nenov D, Paskalev D, Yankova T, Tchankova P.
    Artif Organs; 1995 May; 19(5):436-9. PubMed ID: 7625923
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitative reticulocyte analysis may be of benefit in monitoring erythropoietin treatment in dialysis patients.
    Jeffrey RF, Khan AA, Kendall RG, Norfolk DR, Will EJ, Davison AM.
    Artif Organs; 1995 Aug; 19(8):821-6. PubMed ID: 8573002
    [Abstract] [Full Text] [Related]

  • 18. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers.
    Breymann C, Bauer C, Major A, Zimmermann R, Gautschi K, Huch A, Huch R.
    Br J Haematol; 1996 Feb; 92(2):295-301. PubMed ID: 8602988
    [Abstract] [Full Text] [Related]

  • 19. Effects of recombinant human erythropoietin on sodium balance in nondialysed children with chronic renal failure.
    Kavukçu S, Saatci U, Ciliv G, Söylemezoğlu O, Bakkaloğlu A, Besbas N, Ozen S.
    Int Urol Nephrol; 1993 Feb; 25(6):611-5. PubMed ID: 8175282
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.